These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 21234584)

  • 1. Mehdi-ODM; a modified digital monitoring of the occlusion therapy for amblyopia.
    Gharebaghi AH; Heidary F; Gharebaghi R; Heidary R
    Graefes Arch Clin Exp Ophthalmol; 2011 Jun; 249(6):945-6; author reply 947-8. PubMed ID: 21234584
    [No Abstract]   [Full Text] [Related]  

  • 2. Electronic monitoring of occlusion treatment for amblyopia in patients aged 7 to 16 years.
    Fronius M; Bachert I; Lüchtenberg M
    Graefes Arch Clin Exp Ophthalmol; 2009 Oct; 247(10):1401-8. PubMed ID: 19415317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Use of Electronic Devices for the Treatment of Amblyopia.
    Wagner RS
    J Pediatr Ophthalmol Strabismus; 2017 Jul; 54(4):206. PubMed ID: 28820929
    [No Abstract]   [Full Text] [Related]  

  • 4. P-VEP as predictor of occlusion therapy.
    Singh S; Gautam S
    Korean J Ophthalmol; 2009 Jun; 23(2):135. PubMed ID: 19568368
    [No Abstract]   [Full Text] [Related]  

  • 5. Electronically measured compliance with occlusion therapy for amblyopia is related to visual acuity increase.
    Loudon SE; Polling JR; Simonsz HJ
    Graefes Arch Clin Exp Ophthalmol; 2003 Mar; 241(3):176-80. PubMed ID: 12644939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics of Interocular Suppression in Amblyopic Children during Electronically Monitored Occlusion Therapy: First Insight.
    Kehrein S; Kohnen T; Fronius M
    Strabismus; 2016 Jun; 24(2):51-62. PubMed ID: 27220458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pattern VEP is a useful technique in monitoring the effectiveness of occlusion therapy in amblyopic eyes under occlusion therapy.
    Oner A; Coskun M; Evereklioglu C; Dogan H
    Doc Ophthalmol; 2004 Nov; 109(3):223-7. PubMed ID: 15957607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amblyopia--diagnosis and treatment.
    Kutschke PJ
    Insight; 2009; 34(2):20-3; quiz 24-5. PubMed ID: 19534231
    [No Abstract]   [Full Text] [Related]  

  • 9. Occlusion dose monitoring in amblyopia therapy: status, insights, and future directions.
    Stewart CE; Moseley MJ; Georgiou P; Fielder AR
    J AAPOS; 2017 Oct; 21(5):402-406. PubMed ID: 28890077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Part-time vs. full-time occlusion for amblyopia: evidence for part-time patching.
    Matta NS; Silbert DI
    Am Orthopt J; 2013; 63():14-8. PubMed ID: 24260802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of special computer programs for diagnostics and treatment of amblyopia.
    Tsitsiashvili E
    Georgian Med News; 2007 Sep; (150):7-10. PubMed ID: 17984554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A preliminary report about the relation between visual acuity increase and compliance in patching therapy for amblyopia.
    Loudon SE; Polling JR; Simonsz HJ
    Strabismus; 2002 Jun; 10(2):79-82. PubMed ID: 12221485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful occlusion therapy for amblyopia in 11- to 15-year-old children.
    Haddad HM
    J Pediatr Ophthalmol Strabismus; 2004; 41(4):198; author reply 198. PubMed ID: 15305526
    [No Abstract]   [Full Text] [Related]  

  • 14. Compliance and patching and atropine amblyopia treatments.
    Wang J
    Vision Res; 2015 Sep; 114():31-40. PubMed ID: 25743080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electronic monitoring of treatment compliance in patching for amblyopia.
    Fielder AR
    Surv Ophthalmol; 2000; 44(6):539-40. PubMed ID: 10914521
    [No Abstract]   [Full Text] [Related]  

  • 16. Occlusion treatment for amblyopia: assessing the performance of the electronic occlusion dose monitor.
    Fronius M; Chopovska Y; Nolden J; Loudon SE; Lüchtenberg M; Zubcov A; Pepler L
    Strabismus; 2006 Jun; 14(2):65-70. PubMed ID: 16760110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compliance with the prescribed occlusion treatment for amblyopia.
    Vagge A; Nelson LB
    Curr Opin Ophthalmol; 2017 Sep; 28(5):454-459. PubMed ID: 28617688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electronic recording of occlusion treatment for amblyopia: potential of the new technology.
    Chopovska Y; Loudon SE; Cirina L; Zubcov A; Simonsz HJ; Lüchtenberg M; Fronius M
    Graefes Arch Clin Exp Ophthalmol; 2005 Jun; 243(6):539-44. PubMed ID: 15965674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful occlusion therapy for amblyopia in 11- to 15-year-old children.
    Mohan K; Saroha V; Sharma A
    J Pediatr Ophthalmol Strabismus; 2004; 41(2):89-95. PubMed ID: 15089063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A morphological study of amblyopic eyes in children failing to achieve normal visual acuity after electronically monitored long-term occlusion treatment.
    Kuhli-Hattenbach C; Koss MJ; Kohnen T; Fronius M
    Graefes Arch Clin Exp Ophthalmol; 2015 Nov; 253(11):2021-8. PubMed ID: 26100453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.